James Molloy
Stock Analyst at Alliance Global Partners
(0.04)
# 4,753
Out of 5,028 analysts
284
Total ratings
24.4%
Success rate
-18.6%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACXP Acurx Pharmaceuticals | Reiterated: Buy | $10 | $1.31 | +666.28% | 6 | Sep 30, 2026 | |
| PTHS Pelthos Therapeutics | Reiterated: Buy | $45 | $20.92 | +115.11% | 49 | Sep 28, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $65 | $9.65 | +573.58% | 42 | Sep 28, 2026 | |
| IMNN Imunon | Reiterated: Buy | $12 | $1.34 | +798.88% | 6 | Sep 24, 2026 | |
| QNRX Quoin Pharmaceuticals | Reiterated: Buy | $35 | $4.88 | +617.21% | 5 | Aug 17, 2026 | |
| INTS Intensity Therapeutics | Reiterated: Buy | $30 → $15 | $3.42 | +338.60% | 7 | Aug 11, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $9 | $4.96 | +81.63% | 7 | Aug 7, 2026 | |
| SNGX Soligenix | Reiterated: Buy | $1.5 | $0.365 | +310.96% | 11 | Aug 7, 2026 | |
| ADIL Adial Pharmaceuticals | Initiated Coverage: Buy | $11 | $4.15 | +165.06% | 1 | Aug 3, 2026 | |
| SLS SELLAS Life Sciences Group | Reiterated: Buy | $10 → $25 | $11.51 | +117.20% | 10 | Jul 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.92 | +127.27% | 8 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $3.31 | +443.81% | 1 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.30 | +361.54% | 3 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.477 | +6,189.31% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.03 | +482.52% | 10 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.67 | +92.72% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $1.17 | +199.15% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $30.00 | +83.33% | 6 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.16 | +287.60% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.21 | +1,804.76% | 6 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.96 | +257.14% | 6 | Apr 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.5 | $0.7429 | +505.73% | 8 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 | $4.78 | +56.90% | 4 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 | $9.55 | +2,831.94% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $213 | $0.352 | n/a | 4 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $84 | $4.91 | n/a | 2 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $4.5 | $2.18 | n/a | 3 | Apr 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $490 | $4.41 | n/a | 3 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 | $2.85 | n/a | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $0.2675 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $6.44 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.2 | $0.2302 | n/a | 1 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.85 | n/a | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.15 | n/a | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $7.69 | n/a | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.75 → $3.5 | $0.1735 | n/a | 2 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.5 | $0.000001 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $0.11 | n/a | 1 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $7 | $1.45 | n/a | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $80 | $4.83 | n/a | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $1.37 | n/a | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.1831 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $4 | $1.01 | n/a | 2 | Jul 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.97 | n/a | 1 | Jul 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $16 | $0.001 | n/a | 6 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $40 | $4.69 | n/a | 2 | Nov 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.5 | $1.01 | n/a | 2 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6.5 → $11 | $0.00001 | n/a | 2 | Apr 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $0.0008 | n/a | 1 | Jan 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $5.29 | n/a | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $4.74 | n/a | 1 | Jul 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $0.0751 | n/a | 1 | Oct 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $30 | $1.28 | n/a | 3 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $1.66 | n/a | 1 | Sep 6, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.63 | n/a | 1 | Jan 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $6.92 | n/a | 1 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $20.20 | n/a | 1 | Nov 13, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $4.16 | n/a | 1 | Jul 24, 2013 |
Acurx Pharmaceuticals
Sep 30, 2026
Reiterated: Buy
Price Target: $10
Current: $1.31
Upside: +666.28%
Pelthos Therapeutics
Sep 28, 2026
Reiterated: Buy
Price Target: $45
Current: $20.92
Upside: +115.11%
Tonix Pharmaceuticals Holding
Sep 28, 2026
Reiterated: Buy
Price Target: $65
Current: $9.65
Upside: +573.58%
Imunon
Sep 24, 2026
Reiterated: Buy
Price Target: $12
Current: $1.34
Upside: +798.88%
Quoin Pharmaceuticals
Aug 17, 2026
Reiterated: Buy
Price Target: $35
Current: $4.88
Upside: +617.21%
Intensity Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $30 → $15
Current: $3.42
Upside: +338.60%
Opus Genetics
Aug 7, 2026
Reiterated: Buy
Price Target: $9
Current: $4.96
Upside: +81.63%
Soligenix
Aug 7, 2026
Reiterated: Buy
Price Target: $1.5
Current: $0.365
Upside: +310.96%
Adial Pharmaceuticals
Aug 3, 2026
Initiated Coverage: Buy
Price Target: $11
Current: $4.15
Upside: +165.06%
SELLAS Life Sciences Group
Jul 6, 2026
Reiterated: Buy
Price Target: $10 → $25
Current: $11.51
Upside: +117.20%
Jun 24, 2026
Reiterated: Buy
Price Target: $18
Current: $7.92
Upside: +127.27%
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $18
Current: $3.31
Upside: +443.81%
May 26, 2026
Reiterated: Buy
Price Target: $6
Current: $1.30
Upside: +361.54%
May 21, 2026
Reiterated: Buy
Price Target: $30
Current: $0.477
Upside: +6,189.31%
May 18, 2026
Reiterated: Buy
Price Target: $6
Current: $1.03
Upside: +482.52%
May 14, 2026
Reiterated: Buy
Price Target: $9
Current: $4.67
Upside: +92.72%
May 14, 2026
Reiterated: Buy
Price Target: $3.5
Current: $1.17
Upside: +199.15%
May 14, 2026
Reiterated: Buy
Price Target: $55
Current: $30.00
Upside: +83.33%
May 13, 2026
Reiterated: Buy
Price Target: $20
Current: $5.16
Upside: +287.60%
May 6, 2026
Reiterated: Buy
Price Target: $4
Current: $0.21
Upside: +1,804.76%
Apr 6, 2026
Reiterated: Buy
Price Target: $7
Current: $1.96
Upside: +257.14%
Apr 2, 2026
Reiterated: Buy
Price Target: $4.5
Current: $0.7429
Upside: +505.73%
Feb 19, 2026
Reiterated: Buy
Price Target: $7.5
Current: $4.78
Upside: +56.90%
Nov 19, 2025
Reiterated: Buy
Price Target: $280
Current: $9.55
Upside: +2,831.94%
Jun 17, 2025
Reiterated: Buy
Price Target: $213
Current: $0.352
Upside: n/a
May 22, 2025
Reiterated: Buy
Price Target: $200 → $84
Current: $4.91
Upside: n/a
Apr 15, 2025
Reiterated: Buy
Price Target: $12 → $4.5
Current: $2.18
Upside: n/a
Jan 27, 2025
Reiterated: Buy
Price Target: $490
Current: $4.41
Upside: n/a
Aug 13, 2024
Reiterated: Buy
Price Target: $7.5
Current: $2.85
Upside: n/a
Jul 17, 2024
Initiated Coverage: Buy
Price Target: $3.5
Current: $0.2675
Upside: n/a
Jul 17, 2024
Initiated Coverage: Buy
Price Target: $10
Current: $6.44
Upside: n/a
May 2, 2024
Initiated Coverage: Buy
Price Target: $7.2
Current: $0.2302
Upside: n/a
Mar 7, 2024
Reiterated: Buy
Price Target: $11
Current: $1.85
Upside: n/a
Dec 11, 2023
Initiated Coverage: Buy
Price Target: $30
Current: $1.15
Upside: n/a
Nov 10, 2023
Reiterated: Buy
Price Target: $25
Current: $7.69
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $2.75 → $3.5
Current: $0.1735
Upside: n/a
Mar 6, 2023
Initiated Coverage: Buy
Price Target: $5.5
Current: $0.000001
Upside: n/a
Jan 23, 2023
Initiated Coverage: Buy
Price Target: $80
Current: $0.11
Upside: n/a
Nov 17, 2022
Reiterated: Buy
Price Target: $63 → $7
Current: $1.45
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $80
Current: $4.83
Upside: n/a
Aug 25, 2022
Initiated Coverage: Buy
Price Target: $15
Current: $1.37
Upside: n/a
Aug 5, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.1831
Upside: n/a
Jul 20, 2022
Reiterated: Buy
Price Target: $13 → $4
Current: $1.01
Upside: n/a
Jul 5, 2022
Initiated Coverage: Buy
Price Target: n/a
Current: $2.97
Upside: n/a
Mar 15, 2022
Reiterated: Buy
Price Target: $20 → $16
Current: $0.001
Upside: n/a
Nov 9, 2021
Reiterated: Buy
Price Target: $25 → $40
Current: $4.69
Upside: n/a
Sep 3, 2021
Reiterated: Buy
Price Target: $6.5
Current: $1.01
Upside: n/a
Apr 15, 2021
Reiterated: Buy
Price Target: $6.5 → $11
Current: $0.00001
Upside: n/a
Jan 21, 2021
Initiated Coverage: Buy
Price Target: $35
Current: $0.0008
Upside: n/a
Aug 10, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $5.29
Upside: n/a
Jul 13, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $4.74
Upside: n/a
Oct 8, 2018
Initiated Coverage: Buy
Price Target: $50
Current: $0.0751
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $35 → $30
Current: $1.28
Upside: n/a
Sep 6, 2016
Initiated Coverage: Buy
Price Target: $20
Current: $1.66
Upside: n/a
Jan 27, 2015
Reiterated: Buy
Price Target: $25
Current: $8.63
Upside: n/a
May 15, 2014
Initiated Coverage: Buy
Price Target: $35
Current: $6.92
Upside: n/a
Nov 13, 2013
Initiated Coverage: Buy
Price Target: $30
Current: $20.20
Upside: n/a
Jul 24, 2013
Upgraded: Buy
Price Target: n/a
Current: $4.16
Upside: n/a